248 related articles for article (PubMed ID: 18591367)
21. 5-lipoxygenase and FLAP.
Peters-Golden M; Brock TG
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):99-109. PubMed ID: 12895592
[TBL] [Abstract][Full Text] [Related]
22. Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis.
Coffey MJ; Phare SM; Peters-Golden M
J Immunol; 2000 Oct; 165(7):3592-8. PubMed ID: 11034360
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm.
Di Gennaro A; Wågsäter D; Mäyränpää MI; Gabrielsen A; Swedenborg J; Hamsten A; Samuelsson B; Eriksson P; Haeggström JZ
Proc Natl Acad Sci U S A; 2010 Dec; 107(49):21093-7. PubMed ID: 21078989
[TBL] [Abstract][Full Text] [Related]
24. A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells.
Kargman S; Vickers PJ; Evans JF
J Cell Biol; 1992 Dec; 119(6):1701-9. PubMed ID: 1469057
[TBL] [Abstract][Full Text] [Related]
25. Thiopyranol[2,3,4-c,d]indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthase.
Hutchinson JH; Charleson S; Evans JF; Falgueyret JP; Hoogsteen K; Jones TR; Kargman S; Macdonald D; McFarlane CS; Nicholson DW
J Med Chem; 1995 Oct; 38(22):4538-47. PubMed ID: 7473582
[TBL] [Abstract][Full Text] [Related]
26. Leukotriene receptors and mechanisms of signal transduction.
Crooke ST; Monia BP; Chiang MY; Bennett CF
Ann N Y Acad Sci; 1991; 629():120-4. PubMed ID: 1952543
[TBL] [Abstract][Full Text] [Related]
27. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes.
Ford-Hutchinson AW
Trends Pharmacol Sci; 1991 Feb; 12(2):68-70. PubMed ID: 2024291
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
Gupta N; Nicholson DW; Ford-Hutchinson AW
Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
[TBL] [Abstract][Full Text] [Related]
29. Human bronchial fibroblasts express the 5-lipoxygenase pathway.
James AJ; Penrose JF; Cazaly AM; Holgate ST; Sampson AP
Respir Res; 2006 Jul; 7(1):102. PubMed ID: 16872537
[TBL] [Abstract][Full Text] [Related]
30. Leukotriene synthesis in U937 cells expressing recombinant 5-lipoxygenase.
Kargman S; Rousseau P; Reid GK; Rouzer CA; Mancini JA; Rands E; Dixon RA; Diehl RE; Léveillé C; Nathaniel D
J Lipid Mediat; 1993 May; 7(1):31-45. PubMed ID: 8358023
[TBL] [Abstract][Full Text] [Related]
31. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase.
Abramovitz M; Wong E; Cox ME; Richardson CD; Li C; Vickers PJ
Eur J Biochem; 1993 Jul; 215(1):105-11. PubMed ID: 8344271
[TBL] [Abstract][Full Text] [Related]
32. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
Nieves D; Moreno JJ
Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759
[TBL] [Abstract][Full Text] [Related]
33. Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents.
Werz O; Gerstmeier J; Garscha U
Expert Opin Ther Pat; 2017 May; 27(5):607-620. PubMed ID: 28005436
[TBL] [Abstract][Full Text] [Related]
34. Regulation of leukotriene biosynthesis.
Ford-Hutchinson AW
Cancer Metastasis Rev; 1994 Dec; 13(3-4):257-67. PubMed ID: 7712588
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
Titos E; Clària J; Planagumà A; López-Parra M; González-Périz A; Gaya J; Miquel R; Arroyo V; Rodés J
J Leukoc Biol; 2005 Oct; 78(4):871-8. PubMed ID: 16033810
[TBL] [Abstract][Full Text] [Related]
36. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries.
Allen S; Dashwood M; Morrison K; Yacoub M
Circulation; 1998 Jun; 97(24):2406-13. PubMed ID: 9641692
[TBL] [Abstract][Full Text] [Related]
37. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability.
Qiu H; Gabrielsen A; Agardh HE; Wan M; Wetterholm A; Wong CH; Hedin U; Swedenborg J; Hansson GK; Samuelsson B; Paulsson-Berne G; Haeggström JZ
Proc Natl Acad Sci U S A; 2006 May; 103(21):8161-6. PubMed ID: 16698924
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the production and action of leukotrienes by MK-571 and MK-886.
Ford-Hutchinson AW
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788
[No Abstract] [Full Text] [Related]
39. 5-Lipoxygenase-activating protein homodimer in human neutrophils: evidence for a role in leukotriene biosynthesis.
Plante H; Picard S; Mancini J; Borgeat P
Biochem J; 2006 Jan; 393(Pt 1):211-8. PubMed ID: 16144515
[TBL] [Abstract][Full Text] [Related]
40. 5-lipoxygenase: cellular biology and molecular pharmacology.
Werz O
Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):23-44. PubMed ID: 14561204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
